Cargando…
Is non-cardiac death increased with an initial invasive revascularization strategy? Commentary on the ISCHEMIA trial
Autores principales: | Rodriguez, Alfredo E, Fernandez-Pereira, Carlos, Mieres, Juan, Rodriguez-Granillo, A Matias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242026/ https://www.ncbi.nlm.nih.gov/pubmed/35919125 http://dx.doi.org/10.1093/ehjopen/oeac012 |
Ejemplares similares
-
High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized Data
por: Rodriguez, Alfredo E., et al.
Publicado: (2023) -
Ventricular Septal Perforation after Biventricular Takotsubo Cardiomyopathy Successfully Repaired with an Amplatzer Device: First Report in the Literature
por: Rodríguez, Alfredo E., et al.
Publicado: (2016) -
Cardiac risk factors of revascularization in chronic atherosclerotic lower extremity ischemia
por: Kim, Tae-Yoon, et al.
Publicado: (2013) -
Ventricular tachycardia as the initial symptom of cardiac hydatidosis
por: Lu, Yan-Mei, et al.
Publicado: (2019) -
Commentary on “Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease”
por: Kayadibi, Huseyin, et al.
Publicado: (2014)